- Report
- May 2026
- 15 Pages
Global
From €2761EUR$2,995USD£2,340GBP
- Report
- October 2026
- 479 Pages
Global
From €5393EUR$5,850USD£4,570GBP
- Report
- October 2026
- 528 Pages
Global
From €5393EUR$5,850USD£4,570GBP
- Report
- August 2026
- 120 Pages
Global
From €4379EUR$4,750USD£3,711GBP
- Report
- August 2026
- 116 Pages
Global
From €4379EUR$4,750USD£3,711GBP
- Report
- October 2025
- 160 Pages
Global
From €2913EUR$3,160USD£2,469GBP
€3641EUR$3,950USD£3,086GBP
- Report
- April 2026
- 77 Pages
Global
From €3500EUR$4,067USD£3,070GBP
- Report
- May 2025
- 120 Pages
Global
From €5485EUR$5,950USD£4,648GBP
The Patent Cliff market is a term used to describe the pharmaceutical industry when a large number of drugs come off patent at the same time. This can lead to a decrease in revenue for the companies that manufacture the drugs, as generic versions of the drugs become available. The Patent Cliff market is a period of intense competition between pharmaceutical companies, as they attempt to maintain their market share and profits. Companies must focus on developing new drugs and expanding their product portfolios in order to remain competitive.
Companies in the Patent Cliff market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, and Johnson & Johnson. Show Less Read more